Regenxbio (RGNX) Shares Outstanding (Diluted) (2014 - 2026)
Regenxbio (RGNX) reported Weighted Average Shares Outstanding (Diluted) of 53.02 million for Q2 2026, up 3.0% from 51.48 million a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
For FY2025, Regenxbio posted Weighted Average Shares Outstanding (Diluted) of 51.57 million, up 4.2% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased for three consecutive years, with a five-year compound annual growth rate of 6.7% (FY2020 to FY2025).
- By year, Weighted Average Shares Outstanding (Diluted) came in at 49.51 million in FY2024 (+13.2%), 43.73 million in FY2023 (+1.3%), 43.15 million in FY2022 (-1.7%) and 43.91 million in FY2021 (+17.8%).
- The Q2 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2016.
- Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last 14 quarters, with growth averaging 6.7% over the last eight quarters.
- The high point for year-over-year Weighted Average Shares Outstanding (Diluted) in five years was Q4 2021 (growth of 17.8%); the low point was Q4 2022 (a decline of 1.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 52.43 million (Q1 2026), 51.57 million (Q4 2025) and 51.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | 65.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 65.26 Mn |
| Jun 30, 2026 | 53.02 Mn |
| Mar 31, 2026 | 52.43 Mn |
| Dec 31, 2025 | 51.57 Mn |
| Sep 30, 2025 | 51.69 Mn |
| Jun 30, 2025 | 51.48 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Dec 31, 2024 | 49.51 Mn |
| Sep 30, 2024 | 50.80 Mn |
| Jun 30, 2024 | 50.60 Mn |
| Mar 31, 2024 | 45.73 Mn |
| Dec 31, 2023 | 43.73 Mn |
| Sep 30, 2023 | 43.95 Mn |
| Jun 30, 2023 | 43.53 Mn |
| Mar 31, 2023 | 43.45 Mn |
| Dec 31, 2022 | 43.15 Mn |
| Sep 30, 2022 | 43.25 Mn |
| Jun 30, 2022 | 43.11 Mn |
| Mar 31, 2022 | 42.94 Mn |
| Dec 31, 2021 | 43.91 Mn |
API Access
Regenxbio Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();